Please assess the completion status of the following clinical trial:

Trial Title: Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. A female older than 21 years of age,~2. Have suspicious imaging findings suggesting a possibility of breast cancer, or biopsy-proven breast cancer.~Exclusion Criteria:~1. Pregnant,~2. Unwilling to give informed consent,~3. Have implanted prosthetic heart valves, pacemaker, neuro-stimulation devices, surgical clips (hemostatic clips) or other metallic implants,~4. Have engaged in occupations or activities which may cause accidental lodging of ferromagnetic materials, or have imbedded metal fragments from military activities,~5. Have received orthodontic work involving ferromagnetic materials,~6. Claustrophobic,~7. Have had allergic response to contrast agents (such as iodine or gadolinium) previously,~8. Have known history of severe renal insufficiency, asthma, allergic conditions, sickle cell anemia, chronic hemolytic anemia, and gastrointestinal disorders.

- Gender: FEMALE
- Minimum Age: 21 Years
- Maximum Age: 90 Years
- Healthy Volunteers: t

Study Arms:
- Disease Group (Type: EXPERIMENTAL): Patients with suspicious breast diseases
- Control Group (Type: EXPERIMENTAL): Healthy volunteers for system testing

Based on this trial design, predict the completion outcome and termination type (if applicable).